This is the second session in ACTA's workshop program, 'A Master Class Series on the Development of a Clinical Trial Network (CTN)'.
This Master Class will focus on what clinicians and researchers need to know about the governance of CTNs.
The session will be held on Monday 20th March 2023, 3.30pm (AEDT). The session will be introduced by Mr John Zalcberg OAM (ACTA past-president) and will include a presentation from Ms Megan Sanders (Executive Officer from the Thoracic Oncology Group of Australia), Ayla Barutchu from MAGNET and Donna Goldsmith from ANZICS Clinical Trial Group. The session will cover principles of good governance and the specifics around CTN governance. The session will also include practical examples of governance from the Australian and New Zealand Intensive Care Society (ANZICS), and the Mental Health Australia General Clinical Trial Network (MAGNET).
Future sessions will consider topics such as funding, industry engagement and research proposal evaluation.
Sessions are free of charge and will be held virtually via Zoom.
Latest Resources
-
-
Implementability Guidance Document: After The Trial
-
Assessing the impact of clinical trials: a scoping literature review
-
Research Prioritisation Uncovered – Workshop 2 recording
-
Research Prioritisation Uncovered – Workshop 1 recording
-
Understanding implementability in clinical trials: a pragmatic review and concept map
-
Improving impact of clinical trials through implementability
-
Implementability Super Webinar slide deck
-
Implementability Super Webinar
-
Guidance on Implementability
-
Approaches to implementability, implementation and impact of clinical trials: a survey of Australian clinical trials networks and coordinating centres
-
ANZCA CTN: Impact and Implementation
-
Optimising for Implementation: IMPACT
-
What clinical trialists should know about healthcare policy
-
Implementation of evidence by the ANZICS Clinical Trials Group
-
ALLG Clinical Trials Impact and Implementation
-
Implementation: Clinical Trials
-
What a trialist should know about implementation to practice
-
Cochrane’s approach to implementation
-
The role of AHRTCs in optimising implementation of evidence into practice and policy
-
Economic evaluation of investigator-initiated clinical trials conducted by networks – Appendix: Individual trial-level results
-
Strategies for supporting more trials of high value
-
The Clinician Researcher’s Perspective: Measuring impact on individual clinical practice
-
What we don’t know about the health and economic benefit of trials and registries in Australia
-
What we know about the health and economic benefit of trials and registries in Australia
-
Health system sustainability and continuous self-improvement
-
The Health Service Provider’s Perspective: How should we measure impact on service delivery?